IDEXX Laboratories (IDXX) insider buying

Healthcare · Diagnostics & Research · Market cap $42.2B

8 open-market purchases of IDXX by IDEXX Laboratories's executives and directors since September 2025, worth $0 in total, from SEC Form 4 filings.

The most recent: Ro Khanna bought — on March 30, 2026.

The biggest buyer over the period is Ro Khanna: 6 purchases, $0.

By year

YearPurchasesValue
20264$0
20254$0

Biggest buyers

InsiderBuysValue
Ro Khanna
6$0
Byron Donalds
2$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Mar 30, 2026 Ro Khanna
0$557.09— —
Mar 30, 2026 Ro Khanna
0$557.09— —
Feb 24, 2026 Ro Khanna
0$649.35— —
Feb 24, 2026 Ro Khanna
0$649.35— —
Oct 7, 2025 Ro Khanna
0$627.28— —
Oct 7, 2025 Ro Khanna
0$627.28— —
Sep 4, 2025 Byron Donalds
0$640.44— —
Sep 4, 2025 Byron Donalds
0$640.44— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for IDXX.
Open IDXX in Investingly

Questions

Are IDEXX Laboratories insiders buying the stock?

8 open-market purchases of IDXX by IDEXX Laboratories's executives and directors since September 2025, worth $0 in total, from SEC Form 4 filings. The most recent: Ro Khanna bought — on March 30, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From IDEXX Laboratories's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.